Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy

N Fujino1, M Shimizu, H Ino

  • 1The Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

Clinical Cardiology
|May 11, 2001
PubMed

Insights

Mutations in the cardiac troponin T gene can cause familial hypertrophic cardiomyopathy (HCM) with mild hypertrophy but poor prognosis. This study found the Arg92Trp mutation leads to diverse cardiac changes, including dilated cardiomyopathy.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Cardiology

Background:

  • Familial hypertrophic cardiomyopathy (HCM) linked to cardiac troponin T gene mutations often presents with a poor prognosis despite mild hypertrophy.
  • Serial morphologic changes in HCM patients with cardiac troponin T gene mutations have not been well-documented.

Purpose of the Study:

  • To investigate the long-term clinical and morphological course of patients with familial HCM caused by the cardiac troponin T gene mutation Arg92Trp.
  • To characterize the spectrum of cardiac phenotypes associated with the Arg92Trp mutation.

Main Methods:

  • Screening of 140 probands with familial HCM for mutations in the cardiac troponin T gene.
  • Clinical and echocardiographic assessment of individuals carrying the Arg92Trp mutation.
  • Histopathological analysis of endomyocardial biopsies from affected individuals.

Main Results:

  • The Arg92Trp mutation was identified in 10 individuals from two pedigrees, exhibiting varied cardiac morphologies including dilated cardiomyopathy-like features, asymmetric septal hypertrophy, and electrocardiographic abnormalities.
  • Three patients with dilated cardiomyopathy-like features showed progressive left ventricular dilation.
  • Myocardial biopsies revealed modest hypertrophy, minimal disarray, and mild fibrosis.

Conclusions:

  • The Arg92Trp substitution in the cardiac troponin T gene demonstrates high penetrance, moderate hypertrophy, and a propensity for early progression to dilated cardiomyopathy in Japanese patients.
  • Early identification of individuals with this mutation is crucial for assessing the potential efficacy of early therapeutic interventions.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...